causality:
  cons: Acknowledged limitations in translating animal studies to human outcomes.
  pros: Discussed potential causal relationships between Rapamycin and the given characteristics.
  score: moderate
correctness:
  cons: Did not provide definitive conclusions due to limited human studies and individual
    variability.
  pros: Cited relevant studies and discussed potential effects of Rapamycin on the
    given characteristics.
  score: moderate
general_evaluation:
  cons: Lacked depth in certain areas, such as standardized reporting, longitudinal
    data, and comprehensive toxicity analysis.
  pros: Provided a balanced assessment based on available evidence and encouraged
    consultation with a healthcare provider.
  score: moderate
human_interpretability:
  cons: Some medical terms might require further explanation for a general audience.
  pros: Used clear language and explained concepts in an understandable manner.
  score: good
known_aging_biology:
  cons: Did not provide a detailed discussion of Rapamycin's role in aging biology.
  pros: Mentioned potential immunomodulatory effects of Rapamycin in aging individuals.
  score: moderate
longitudinal_data:
  cons: Did not incorporate longitudinal data in the assessment.
  score: bad
standardized_analysis_and_reporting:
  cons: Did not use standardized reporting formats or analysis methods.
  score: bad
toxicity_and_holistic_evidence:
  cons: Did not provide a comprehensive overview of potential side effects or drug
    interactions.
  pros: Mentioned the need to consult a healthcare provider to consider potential
    risks.
  score: moderate
usefulness_and_comprehensiveness:
  cons: Could have provided more specific guidance on dosing and potential risks.
  pros: Addressed each characteristic separately and provided an aggregated assessment.
  score: moderate
